Docebo Inc
NASDAQ:DCBO
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
34.39
54.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Wall Street
Price Targets
DCBO Price Targets Summary
Docebo Inc
According to Wall Street analysts, the average 1-year price target for DCBO is 40.13 USD with a low forecast of 32.85 USD and a high forecast of 46.68 USD.
DCBO Last Price Targets
Docebo Inc
The latest public price target was made on Sep 16, 2024 by
Kevin Kumar
from
Goldman Sachs
,
who expects
DCBO
stock to
rise by 10%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Kevin Kumar
Goldman Sachs
|
48
USD
Upside 10% |
3 days ago
Sep 16, 2024
|
Goldman Sachs Reiterates Neutral Rating on Docebo Inc. (DCBO)
StreetInsider
|
Ryan MacDonald
Needham
|
50
USD
Upside 15% |
1 week ago
Sep 12, 2024
|
Docebo Inc. (DCBO) PT Raised to $50 at Needham
StreetInsider
|
Robert Young
Canaccord Genuity
|
54
USD
Upside 24% |
1 month ago
Aug 9, 2024
|
Docebo Inc. (DCBO) PT Lowered to $54 at Canaccord Genuity
StreetInsider
|
|
George Sutton
Craig-Hallum
|
58
USD
Upside 33% |
3 months ago
Jun 7, 2024
|
Docebo initiated with a Buy at Craig-Hallum
TheFly
|
Kevin Krishnaratne
Scotiabank
|
50
USD
Upside 15% |
4 months ago
May 14, 2024
|
Docebo Inc. (DCBO) PT Lowered to $50 at Scotiabank
StreetInsider
|
|
Robert Young
Canaccord Genuity
|
55
USD
Upside 26% |
4 months ago
May 14, 2024
|
Docebo Inc. (DCBO) PT Lowered to $55 at Canaccord Genuity
StreetInsider
|
|
Ryan MacDonald
Needham
|
56
USD
Upside 29% |
10 months ago
Nov 14, 2023
|
Docebo Poised To Deliver A Balanced Mix Of Growth & Profitability In FY24: Analyst
Benzinga
|
Josh Baer
Morgan Stanley
|
49
USD
Upside 13% |
1 year ago
Aug 18, 2023
|
Morgan Stanley Upgrades Docebo Inc. (DCBO) to Overweight
StreetInsider
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is DCBO's stock price target?
Price Target
40.13
USD
According to Wall Street analysts, the average 1-year price target for DCBO is 40.13 USD with a low forecast of 32.85 USD and a high forecast of 46.68 USD.
What is Docebo Inc's Revenue forecast?
Projected CAGR
17%
For the last 6 years the compound annual growth rate for Docebo Inc's revenue is 48%. The projected CAGR for the next 3 years is 17%.
What is Docebo Inc's Operating Income forecast?
Projected CAGR
307%
The compound annual growth rate of Docebo Inc's operating income for the next 3 years is 307%.
What is Docebo Inc's Net Income forecast?
Projected CAGR
135%
The compound annual growth rate of Docebo Inc's net income for the next 3 years is 135%.
You don't have any saved screeners yet
